Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 2/20 | 0.45 |
| ▸ | IDO1 | P14902 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 3/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5021265 | 1.00 | AGXT (0.45) | AGXTIDO1CYP1A2CYP2A6TAAR1 | |
| SCHEMBL1784538 | 0.83 | TP53 (0.37) | IDO1CYP2A6TAAR1ALDH1A1TP53 | |
| SCHEMBL5021267 | 0.83 | TP53 (0.37) | IDO1CYP2A6TAAR1ALDH1A1TP53 | |
| SCHEMBL11400752 | 0.81 | MAOB (0.52) | AGXTIDO1CYP1A2CYP2A6TAAR1 | |
| SCHEMBL15870434 | 0.81 | IDO1 (0.43) | IDO1CYP2A6TAAR1ALDH1A1TP53 | |
| SCHEMBL5598799 | 0.81 | ALDH1A1 (0.59) | AGXTIDO1TAAR1ALDH1A1TP53 | |
| SCHEMBL5032523 | 0.81 | IDO1 (0.45) | IDO1TAAR1ALDH1A1CA2 | |
| SCHEMBL1789139 | 0.81 | ALDH1A1 (0.59) | CYP1A2ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL625599 | 0.80 | MAOB (0.61) | AGXTIDO1ALDH1A1TP53TSHR | |
| SCHEMBL1781025 | 0.80 | MAOB (0.61) | AGXTIDO1ALDH1A1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110118170-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2011-05-19 | — | — | US | claimed |
| US-8168834-B2 | 4-alkyl 1-(3-methoxy-2-propen-1-yl) benzene compounds and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2012-05-01 | — | — | US | disclosed |
| US-20110118509-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2011-05-19 | — | — | US | disclosed |
| US-20110118170-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2011-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118509-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | TRPA1, OR51E2, CYP1B1 | AGXT 3040/4885IDO1 690/4885CYP1A2 55/4885 |
| US-20110118170-A1 | NOVEL 4-ALKYL 1-(3-METHOXY-2-PROPEN-1-YL) BENZENE COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS | TRPA1, OR51E2, CYP1B1 | AGXT 3040/4885IDO1 690/4885CYP1A2 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.